Artivion (AORT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $21.78, -0.41% vs the prior close of $21.87.
- Volume 433.65K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AORT dips 0.4% to $21.78. Closed at $21.78, -0.41% vs the prior close of $21.87. Day range $21.64–$22.37, opened at $21.83.
AORT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AORT dips 0.4% to $21.78
- Closed at $21.78, -0.41% vs the prior close of $21.87. Day range $21.64–$22.37, opened at $21.83.
- Volume was 433.65K shares, 0.7x its 50-day average of 648.53K.
- Price is -12.5% vs its 50-day average ($24.90) and -28.5% vs its 200-day average ($30.45).
- 52-week range $19.16–$48.25; today's close sits at 9% of that range, 54.9% below the 52-week high.
Oct 15, 2026 — AORT rises 1.6% to $21.87
- Closed at $21.87, +1.58% vs the prior close of $21.53. Day range $21.53–$22.49, opened at $22.02.
- Volume was 512.50K shares, 0.8x its 50-day average of 657.56K.
- Price is -12.5% vs its 50-day average ($25.00) and -28.5% vs its 200-day average ($30.57).
- 52-week range $19.16–$48.25; today's close sits at 9% of that range, 54.7% below the 52-week high.
Oct 14, 2026 — AORT rises 0.8% to $21.53
- Closed at $21.53, +0.80% vs the prior close of $21.36. Day range $21.08–$21.75, opened at $21.32.
- Volume was 488.50K shares, 0.7x its 50-day average of 659.25K.
- Price is -14.2% vs its 50-day average ($25.08) and -29.9% vs its 200-day average ($30.69).
- 52-week range $19.16–$48.25; today's close sits at 8% of that range, 55.4% below the 52-week high.
Oct 13, 2026 — AORT dips 2.0% to $21.36
- Closed at $21.36, -1.97% vs the prior close of $21.79. Day range $21.30–$22.40, opened at $21.83.
- Volume was 664.60K shares, 1.0x its 50-day average of 662.59K.
- Price is -15.2% vs its 50-day average ($25.19) and -30.7% vs its 200-day average ($30.82).
- 52-week range $19.16–$48.25; today's close sits at 8% of that range, 55.7% below the 52-week high.
Oct 12, 2026 — AORT rises 2.5% to $21.79
- Closed at $21.79, +2.49% vs the prior close of $21.26. Day range $21.09–$21.91, opened at $21.21.
- Volume was 436.60K shares, 0.7x its 50-day average of 666.15K.
- Price is -13.9% vs its 50-day average ($25.31) and -29.6% vs its 200-day average ($30.94).
- 52-week range $19.16–$48.25; today's close sits at 9% of that range, 54.8% below the 52-week high.
Oct 9, 2026 — AORT ends flat (+0.2%) to $21.26
- Closed at $21.26, +0.24% vs the prior close of $21.21. Day range $20.21–$21.60, opened at $21.15.
- Volume was 343.50K shares, 0.5x its 50-day average of 673.53K — lighter than usual.
- Price is -16.3% vs its 50-day average ($25.41) and -31.6% vs its 200-day average ($31.07).
- 52-week range $19.16–$48.25; today's close sits at 7% of that range, 55.9% below the 52-week high.
Oct 8, 2026 — AORT dips 1.9% to $21.21, a 3-month low, 3 down days in a row
- Closed at $21.21, -1.85% vs the prior close of $21.61. Day range $20.89–$21.45, opened at $21.45.
- Volume was 602.20K shares, 0.9x its 50-day average of 676.77K.
- Price is -17.0% vs its 50-day average ($25.54) and -32.0% vs its 200-day average ($31.20).
- 52-week range $19.16–$48.25; today's close sits at 7% of that range, 56.0% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — AORT dips 1.1% to $21.61, a 3-month low
- Closed at $21.61, -1.05% vs the prior close of $21.84. Day range $21.59–$22.40, opened at $21.80.
- Volume was 352.00K shares, 0.5x its 50-day average of 679.94K — lighter than usual.
- Price is -15.8% vs its 50-day average ($25.67) and -31.0% vs its 200-day average ($31.33).
- 52-week range $19.16–$48.25; today's close sits at 8% of that range, 55.2% below the 52-week high.
Oct 6, 2026 — AORT slides 3.4% to $21.84, a 3-month low
- Closed at $21.84, -3.41% vs the prior close of $22.61. Day range $21.65–$23.31, opened at $22.83.
- Volume was 494.30K shares, 0.7x its 50-day average of 678.61K.
- Price is -15.3% vs its 50-day average ($25.77) and -30.6% vs its 200-day average ($31.45).
- 52-week range $19.16–$48.25; today's close sits at 9% of that range, 54.7% below the 52-week high.
Oct 5, 2026 — AORT rises 1.3% to $22.61
- Closed at $22.61, +1.34% vs the prior close of $22.31. Day range $22.16–$23.04, opened at $22.21.
- Volume was 734.20K shares, 1.1x its 50-day average of 671.32K.
- Price is -12.6% vs its 50-day average ($25.86) and -28.4% vs its 200-day average ($31.58).
- 52-week range $19.16–$48.25; today's close sits at 12% of that range, 53.1% below the 52-week high.
Oct 2, 2026 — AORT rises 1.7% to $22.31
- Closed at $22.31, +1.73% vs the prior close of $21.93. Day range $21.60–$22.72, opened at $22.07.
- Volume was 559.40K shares, 0.8x its 50-day average of 671.85K.
- Price is -13.9% vs its 50-day average ($25.91) and -29.6% vs its 200-day average ($31.70).
- 52-week range $19.16–$48.25; today's close sits at 11% of that range, 53.8% below the 52-week high.
AORT latest news & SEC filings
Every SEC filing by or about AORT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Green Andrew M sold 11,480 shares at $24.97 (≈$286.66K) on Sep 10, 2026
- Green Andrew M sold 11,480 shares at $24.97 (≈$286.66K) on Sep 10, 2026
- Green Andrew M sold 11,480 shares at $24.97 (≈$286.66K) on Sep 10, 2026
- Green Andrew M sold 11,480 shares at $24.97 (≈$286.66K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Green Andrew M sold 1,493 shares at $26.02 (≈$38.85K) on Sep 3, 2026
- Green Andrew M sold 1,493 shares at $26.02 (≈$38.85K) on Sep 3, 2026
- Green Andrew M sold 1,493 shares at $26.02 (≈$38.85K) on Sep 3, 2026
- Green Andrew M sold 1,493 shares at $26.02 (≈$38.85K) on Sep 3, 2026
- Green Andrew M sold 6,510 shares at $27.27 (≈$177.53K) on Sep 2, 2026
- Green Andrew M sold 6,510 shares at $27.27 (≈$177.53K) on Sep 2, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 27, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $125.76M (prior year $112.97M) (+11.3% vs Jun 30, 2025)
- Net income: -$13.51M (prior year $1.34M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.28 (prior year $0.03) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade AORT
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.62% (largest 3.9%).
- Liquidity: about 507.78K shares (≈$11.06M) trade per day on average.
- 52-week position: $21.78 vs a range of $19.16–$48.25 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Andrew M Green sold 11,480 shares on Sep 10, 2026.
- Latest filings: 10-Q Aug 7, 2026; 8-K Aug 6, 2026; 8-K May 18, 2026.
- Share count: 48.76M shares outstanding (Jul 31, 2026), +3.3% vs a year earlier.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
AORT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 21.83 | 22.37 | 21.64 | 21.78 | 433.65K |
| Oct 15, 2026 | 22.02 | 22.49 | 21.53 | 21.87 | 512.50K |
| Oct 14, 2026 | 21.32 | 21.75 | 21.08 | 21.53 | 488.50K |
| Oct 13, 2026 | 21.83 | 22.40 | 21.30 | 21.36 | 664.60K |
| Oct 12, 2026 | 21.21 | 21.91 | 21.09 | 21.79 | 436.60K |
| Oct 9, 2026 | 21.15 | 21.60 | 20.21 | 21.26 | 343.50K |
| Oct 8, 2026 | 21.45 | 21.45 | 20.89 | 21.21 | 602.20K |
| Oct 7, 2026 | 21.80 | 22.40 | 21.59 | 21.61 | 352.00K |
| Oct 6, 2026 | 22.83 | 23.31 | 21.65 | 21.84 | 494.30K |
| Oct 5, 2026 | 22.21 | 23.04 | 22.16 | 22.61 | 734.20K |
| Oct 2, 2026 | 22.07 | 22.72 | 21.60 | 22.31 | 559.40K |
| Oct 1, 2026 | 22.87 | 23.11 | 21.86 | 21.93 | 501.70K |
| Sep 30, 2026 | 22.91 | 23.11 | 22.64 | 22.82 | 501.40K |
| Sep 29, 2026 | 22.90 | 23.07 | 22.41 | 22.86 | 336.50K |
| Sep 28, 2026 | 22.63 | 23.21 | 22.42 | 22.95 | 446.10K |
| Sep 25, 2026 | 23.06 | 23.30 | 22.52 | 22.63 | 502.80K |
| Sep 24, 2026 | 23.59 | 23.72 | 23.00 | 23.03 | 567.20K |
| Sep 23, 2026 | 24.15 | 24.76 | 23.03 | 23.53 | 504.00K |
| Sep 22, 2026 | 23.93 | 24.15 | 23.44 | 24.13 | 605.40K |
| Sep 21, 2026 | 23.27 | 23.72 | 22.92 | 23.63 | 569.10K |
About Artivion
Artivion (AORT) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in KENNESAW, GA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 784199.
AORT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas F Ackerman | Director | May 20, 2026 |
| Daniel J Bevevino | Director | May 20, 2026 |
| Marna P Borgstrom | Director | May 20, 2026 |
| James Bullock | Director | May 20, 2026 |
| Jeffrey H Burbank | Director | May 20, 2026 |
| Elizabeth A Hoff | Director | May 20, 2026 |
| Anthony B. Semedo | Director | Jun 4, 2026 |
| Jon W Salveson | Director | May 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lance A Berry | EVP, COO, CFO & Treasurer | Aug 17, 2026 |
| John E Davis | Chief Commercial Officer | Mar 4, 2026 |
| Andrew M Green | SVP, Regulatory and Quality | Sep 11, 2026 |
| Jean F Holloway | SVP, General Counsel | Aug 12, 2026 |
| Amy Horton | VP, Chief Accounting Officer | Mar 4, 2026 |
| James P Mackin | President & CEO | Aug 20, 2026 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | Mar 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Andrew M Green | Sale | 11,480 | $24.97 |
| Sep 10, 2026 | Andrew M Green | Sale | 11,480 | $24.97 |
| Sep 10, 2026 | Andrew M Green | Sale | 11,480 | $24.97 |
| Sep 10, 2026 | Andrew M Green | Sale | 11,480 | $24.97 |
| Sep 3, 2026 | Andrew M Green | Sale | 1,493 | $26.02 |
| Sep 3, 2026 | Andrew M Green | Sale | 1,493 | $26.02 |
| Sep 3, 2026 | Andrew M Green | Sale | 1,493 | $26.02 |
| Sep 3, 2026 | Andrew M Green | Sale | 1,493 | $26.02 |
| Sep 2, 2026 | Andrew M Green | Sale | 6,510 | $27.27 |
| Sep 2, 2026 | Andrew M Green | Sale | 6,510 | $27.27 |
| Sep 2, 2026 | Andrew M Green | Sale | 6,510 | $27.27 |
| Sep 2, 2026 | Andrew M Green | Sale | 6,510 | $27.27 |
| Aug 19, 2026 | James P Mackin | Sale | 70,000 | $28.96 |
| Aug 19, 2026 | James P Mackin | Sale | 70,000 | $28.96 |
| Aug 19, 2026 | James P Mackin | Sale | 70,000 | $28.96 |
AORT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $441.33M | $9.77M | 0.21 | $39.88M |
| Dec 31, 2024 | $388.54M | $-13.36M | -0.32 | $22.24M |
| Dec 31, 2023 | $354.00M | $-30.69M | -0.75 | $18.82M |
| Dec 31, 2022 | $313.79M | $-19.19M | -0.48 | $-5.15M |
| Dec 31, 2021 | $298.84M | $-14.83M | -0.38 | $-2.58M |
Latest balance sheet: total assets $1.07B, total liabilities $626.35M, cash $77.32M (as of Jun 30, 2026).
AORT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $26.57 |
| May 7, 2026 | 8-K Item 2.02 (results) | $35.42 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $40.65 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $47.50 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $32.70 |
| May 5, 2025 | 8-K Item 2.02 (results) | $23.77 |
| Feb 24, 2025 | 8-K Item 2.02 (results) | $27.85 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $28.98 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AORT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.